Literature DB >> 8738430

Generation of lymphocyte cell lines coexpressing CD4 and wild-type or mutant HIV type 1 glycoproteins: implications for HIV type 1 Env-induced cell lysis.

U Krüger1, T Pfeiffer, V Bosch.   

Abstract

To gain more insight into the processes leading to HIV-1 Env-induced cell death, we aim to coexpress stably wild-type and relevant mutant variants of both HIV-1 Env and human CD4 in lymphocyte cell lines. Here we report on the generation and characterization of several cell lines inducibly or constitutively expressing wild-type or cleavage-defective HIV-1 glycoproteins and human CD4 either singly or in combination. Coexpression of CD4 and wild-type Env led to the formation of multinucleated syncytia, to growth arrest and cell death, effects that all could be prevented by cultivation in the presence of monoclonal antibodies that inhibit cell surface membrane fusion. Cell lines coexpressing CD4 and mutated, noncleavable Env, detectable at the cell surface and still retaining CD4-binding capacity, were not retarded in their growth and cytolysis did not occur. These results indicate that cell lysis requires cell surface interaction of CD4 and gp120/41 and cleavage of gp160 to gp120 and gp41.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738430     DOI: 10.1089/aid.1996.12.783

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.

Authors:  B S Schnierle; J Stitz; V Bosch; F Nocken; H Merget-Millitzer; M Engelstädter; R Kurth; B Groner; K Cichutek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

2.  The Role of the Envelope Glycoprotein in the Depletion of T Helper Cells in Human Immunodeficiency Virus Infection.

Authors:  Christian Jassoy; Martin Heinkelein; Sieghart Sopper
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

3.  Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28).

Authors:  Donatien Mavoungou; Virginie Poaty-Mavoungou; Marie-Yvonne Akoume; Brice Ongali; Elie Mavoungou
Journal:  Virol J       Date:  2005-02-11       Impact factor: 4.099

4.  A neutralization assay for chikungunya virus infections in a multiplex format.

Authors:  Christopher Weber; Renate König; Matthias Niedrig; Petra Emmerich; Barbara S Schnierle
Journal:  J Virol Methods       Date:  2014-02-16       Impact factor: 2.014

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.